| Name | Title | Contact Details |
|---|
Accent Biomedical is a Stow, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Us Health Connect is a Fort Washington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SunFlora, Inc. was founded in 2018 by husband-and-wife team Marcus and Rachael Quinn to produce quality hemp-derived products for health and wellness, skincare, and pets.
MEDSEEK provides healthcare organizations with Enterprise eHealth solutions to fully engage and strengthen relationships with key constituents, physicians, patients, employees and consumers.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.